Kinnate Biopharma Inc.
KNTEDelisted Apr 3, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001797768
Kinnate Biopharma Inc. was delisted on Apr 3, 2024; its insiders filed their last Form 4 on Apr 5, 2024; 56 institutions reported holding it in 13F filings for Q1 2024, worth $92.2M in total; Viking Global Investors was the only superinvestor holding it.
Superinvestors holding KNTE, Q1 2024
1 superinvestor reports holding Kinnate Biopharma Inc. on Form 13F, worth $4.84M in total. Weight is Kinnate Biopharma Inc.'s share of each 13F portfolio; actions compare shares with Q4 2023.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Viking Global InvestorsAndreas Halvorsen | <0.1% | 1,820,462 | $4.84M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of KNTE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−2.8%)